ARTICLE | Company News
Antisoma, Bryan Oncor deal
August 17, 2009 7:00 AM UTC
Antisoma granted cancer company Bryan Oncor an exclusive, worldwide license to develop and commercialize P2045. The somatostatin receptor-binding peptide combined with rhenium-188 isotope has complete...